Koninklijke Philips NV (PHG)
26.38
+0.07
(+0.27%)
USD |
NYSE |
Nov 21, 16:00
26.38
0.00 (0.00%)
After-Hours: 20:00
Koninklijke Philips Enterprise Value: 29.34B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 29.34B |
| November 20, 2024 | 29.27B |
| November 19, 2024 | 28.97B |
| November 18, 2024 | 28.95B |
| November 15, 2024 | 28.85B |
| November 14, 2024 | 28.76B |
| November 13, 2024 | 28.96B |
| November 12, 2024 | 28.96B |
| November 11, 2024 | 29.41B |
| November 08, 2024 | 29.55B |
| November 07, 2024 | 30.40B |
| November 06, 2024 | 29.47B |
| November 05, 2024 | 29.97B |
| November 04, 2024 | 29.97B |
| November 01, 2024 | 29.44B |
| October 31, 2024 | 29.18B |
| October 30, 2024 | 29.28B |
| October 29, 2024 | 29.76B |
| October 28, 2024 | 29.56B |
| October 25, 2024 | 34.13B |
| October 24, 2024 | 34.60B |
| October 23, 2024 | 34.34B |
| October 22, 2024 | 34.51B |
| October 21, 2024 | 34.56B |
| October 18, 2024 | 34.48B |
| Date | Value |
|---|---|
| October 17, 2024 | 34.21B |
| October 16, 2024 | 34.68B |
| October 15, 2024 | 34.55B |
| October 14, 2024 | 34.78B |
| October 11, 2024 | 34.55B |
| October 10, 2024 | 34.28B |
| October 09, 2024 | 34.74B |
| October 08, 2024 | 34.34B |
| October 07, 2024 | 34.24B |
| October 04, 2024 | 34.81B |
| October 03, 2024 | 34.49B |
| October 02, 2024 | 34.85B |
| October 01, 2024 | 35.04B |
| September 30, 2024 | 35.09B |
| September 27, 2024 | 35.10B |
| September 26, 2024 | 34.04B |
| September 25, 2024 | 33.48B |
| September 24, 2024 | 33.34B |
| September 23, 2024 | 32.76B |
| September 20, 2024 | 33.15B |
| September 19, 2024 | 33.44B |
| September 18, 2024 | 33.41B |
| September 17, 2024 | 33.70B |
| September 16, 2024 | 33.51B |
| September 13, 2024 | 33.29B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
17.94B
Minimum
Nov 03 2022
59.68B
Maximum
Apr 23 2021
36.45B
Average
31.42B
Median
Enterprise Value Benchmarks
| DBV Technologies SA | 3.136M |
| Edap TMS SA | 66.68M |
| Adaptimmune Therapeutics PLC | 33.86M |
| Akari Therapeutics PLC | 29.10M |
| NuCana PLC | -11.85M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.085B |
| Revenue (Quarterly) | 4.495B |
| Total Expenses (Quarterly) | 5.389B |
| EPS Diluted (Quarterly) | -1.195 |
| Gross Profit Margin (Quarterly) | 43.86% |
| Profit Margin (Quarterly) | -24.14% |
| Earnings Yield | -3.66% |
| Normalized Earnings Yield | -3.622 |